Abstract
Propafenone is an effective agent for suppression of chronic ventricular ectopic depolarizations. Complete elimination of nonsustained ventricular tachycardia is achieved in most patients treated with propafenone. The efficacy of propafenone is best correlated with its prolongation of the PR and QRS intervals whereas its plasma level is a poor predictor of therapeutic efficacy. Although serious side effects do occur with propafenone therapy and the drug must be discontinued in some patients, successful therapy of patients for up to four years has been reported.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 528-534 |
| Number of pages | 7 |
| Journal | Clinical Progress in Electrophysiology and Pacing |
| Volume | 4 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 1986 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Hotter monitoring
- N‐demethyl‐propafenone
- flecainide
- hydroxypmpafenone
- mexiletine
- pharmacodynamics
- side effects
Fingerprint
Dive into the research topics of 'The Efficacy of Propafenone for Treatment of Ventricular Ectopic Depolarizations'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS